Test Directory
Beta-2 Glycoprotein I Antibody (IgG, IgM, IgA)
Justification
Beta-2 Glycoprotein I (B2GPI) antibodies are associated with antiphospholipid syndrome (APS). Persistently elevated levels of B2GPI antibodies are associated with an increased risk of vascular thrombosis and obstetrical complications.
STAT: < 48 hours (M-F)
CIA
Draw Tube: Red Top
Sample Type: Serum
Specimen Requirements
Sample Type | Volume Required | Minimum Volume | Stability | |
---|---|---|---|---|
PREFERRED | Serum | 1mL | 0.5mL | Room Temp.: 7 days
Refrigerated: 14 days Frozen (-20C): 1 month Frozen (-80C): 6 months |
ALTERNATIVE | Citrated Plasma | 1mL | - | Frozen (-20C): 1 month
Frozen (-80C): 6 months |
REJECTION CRITERIA | Thawed in transit, refrozen or clotted sample |
SPECIAL INSTRUCTIONS | - |
General Information
METHODOLOGY | CIA |
STAT TAT | < 48 hours (M-F) |
STAT TAT Performance | > 90% of results released in 48 hours |
ROUTINE TAT | < 3 days (M-F) |
ALTERNATIVE NAMES | B2GPI, B2GP1 |
DESCRIPTION | This assay employs an FDA-approved, chemiluminescent immunoassay (CIA) method and reports in arbitrary chemiluminescent units (CU). |
LIMITATIONS | - |
NORMAL RANGE | < 20 CU |
ASSOCIATED TESTING | - |
REFERENCES | - |
SAMPLE REPORT | Upon request |
NEW YORK STATE APPROVED | - |
Test Codes
ORDER CODE | P3311 |
CPT CODE | 86146x3 |
LOINC CODE | 16135-6, 21108-6, 16136-4 |